EU Sets The Stage For Increased Pharmacovigilance Oversight And Harmonization
17 February 2014
With the overarching goal of improving transparency and accountability, the European Medicines Agency (EMA) has been taking a more comprehensive approach to pharmacovigilance, introducing a set of good pharmacovigilance practice (GVP) guidelines to the European market.
Russian Minister of Health: real medical empire created for guests of Olympic Sochi
17 February 2014
An “entire medical empire” has been created for residents and guests of Russia’s Black Sea resort Sochi, which is hosting the 22nd Olympic Winter Games, Russian Minister of Health Veronika Skvortsova said in an interview published in Thursday’s issue of the Rossiiskaya Gazeta daily.
US biotech stocks soar to new record high
17 February 2014
Investors are buying further into booming US biotechnology stocks, with the sector soaring to a new record after delivering double-digit returns in 2014.
Illumina and Yuri Milner will back a genomics startup incubator in San Francisco
14 February 2014
Illumina ($ILMN) is throwing its cachet and its $1,000 genome sequencing system behind a San Francisco genomics startup incubator backed by Russian billionaire Yuri Milner.
U.S. rep rips the FDA's efforts to speed up drug approvals
11 February 2014
Over the past few years, the FDA has unveiled a spate of new approval pathways in hopes of getting much-needed treatments on the market faster. But in the rush to accelerate drug development, the agency has wound up putting patients at risk, according to one congresswoman, fast-tracking unproven therapies despite serious safety concerns.
Nuvo Research Announces the U.S. Commercial Launch of PENNSAID® 2% by Mallinckrodt
11 February 2014
Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced the U.S. commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%) by its U.S. commercial licenseeMallinckrodt (NYSE:MNK).
BRICS Medical Device Market Reports
10 February 2014
With a combined population of 3 0 billion people and with significant unmet medical need, the challenges and opportunities of the BRIC markets are considerable The economic downturn has affected these markets varyingly; for example, the Brazilian import market may be affected by disadvantageous US$ exchange rates, but China is affected more by a weak economy in the USA, its major market Significant growth rates are impressive, but the low starting point – along with a range of other operational issues – means companies must be targeted in the opportunities they pursue.
Reports Of U.S. Biomedical R&D Demise – A Great Exaggeration
06 February 2014
Prior to heading out to the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco last month, I stumbled across several article headlines indicating the United States’ domination of global biomedical R&D was fading. What metric was used to determine this? R&D spend. According to “new” research from the University of Michigan Health System, the U.S. share of the global biomedical R&D business declined from 51 percent to a mere 45 percent from 2007 to 2012.
Russian physicians visit ARMC, learn about healthcare and hospital systems in US
06 February 2014
Delegates of Russia’s health care community toured Athens Regional Medical Center on Tuesday as part of trip sponsored by Rotary International and the Athens Rotary Club to learn more about health care practices in the United States and technology used in American hospitals.
Collaborations between foreign and domestic pharma companies in Russia mark the start of a trend
05 February 2014
Over the past few months, there has been a steady inflow of news about collaboration between foreign pharma companies and Russian firms, along with news about foreign companies basing production processes in Russia.
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024